Cargando…
Eosinophilic granulomatosis with polyangiitis (EGPA) with low activity EBV replication during the COVID 19 pandemic
Autores principales: | Mueller, Melina, Poller, Wolfgang, Klingel, Karin, Neumann, Thomas, Landmesser, Ulf, Heidecker, Bettina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828429/ https://www.ncbi.nlm.nih.gov/pubmed/35165658 http://dx.doi.org/10.1016/j.ijcha.2022.100968 |
Ejemplares similares
-
Neurological Complications in Eosinophilic Granulomatosis with Polyangiitis (EGPA): The Roles of History and Physical Examinations in the Diagnosis of EGPA
por: Oiwa, Hiroshi, et al.
Publicado: (2017) -
Eosinophilic Granulomatosis with Polyangiitis (EGPA): A case report with atypical presentation
por: Mahmood, Khalid, et al.
Publicado: (2023) -
Gut Microbiota and Associated Mucosal Immune Response in Eosinophilic Granulomatosis with Polyangiitis (EGPA)
por: Niccolai, Elena, et al.
Publicado: (2022) -
Severe heart failure in the setting of inflammatory cardiomyopathy with likely pathogenic titin variant
por: Mueller, Melina, et al.
Publicado: (2022) -
Omalizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): single-center experience in 18 cases
por: Celebi Sozener, Zeynep, et al.
Publicado: (2018)